ADHD Screening

Foundational Context

The ASRS was developed to address the need for a brief, accurate adult ADHD screener that could be used in both clinical and general population settings. Prior to its creation, most ADHD measures were designed for children or required lengthy clinician administration. The ASRS v1.1 was validated through a large World Health Organization World Mental Health Survey sample (Kessler et al., 2005), demonstrating strong performance as a short screener.

Part A (the 6-item screener) includes items with the highest predictive power for identifying potential ADHD cases. Part B offers a fuller view of symptom frequency but is not used for diagnostic cutoffs. Together, they provide an accessible, structured approach to detecting potential ADHD symptoms in adults who may not have been identified earlier in life.

What the Assessment Measures

The ASRS evaluates symptom frequency across core ADHD domains, reflecting DSM-IV/DSM-5-TR criteria for adult presentations. It focuses on the real-world expression of symptoms in daily functioning, including both attentional and hyperactive-impulsive patterns.

The ASRS measures:

• Inattention: difficulty sustaining focus, disorganization, forgetfulness, task avoidance
• Hyperactivity: restlessness, trouble sitting still, excessive activity
• Impulsivity: interrupting, difficulty waiting, acting without thinking
• Task initiation and completion: starting tasks, following through on responsibilities
• Executive functioning challenges: planning, prioritizing, and working memory issues

These domains help clinicians understand whether symptom patterns align with common adult ADHD profiles, without implying diagnostic determination.

Interpretation Guidelines

Part A (6-Item Screener):

• A score meeting the published rule (4 or more items in the “elevated frequency” range) suggests the individual is likely to meet criteria for ADHD upon further evaluation.
• This is not a diagnosis, but a validated trigger for deeper assessment.

Part B (12 Symptom Items):

• Provides a broader view of symptom expression and functional impact.
• Higher frequency responses indicate more persistent ADHD-like patterns.
• Clinicians often use Part B to explore domain-specific impairments or to guide interview follow-up.

Global Considerations:

• Self-report may be influenced by mood, stress, insight, or coping mechanisms.
• ADHD symptoms must cause functional impairment to meet diagnostic criteria, the ASRS does not assess impairment directly.
• Elevated scores warrant contextual evaluation through interview, collateral information, and functional assessment.

Psychometric Properties

Reliability

• Strong internal consistency across both Part A and Part B
• High test–retest reliability in adult samples
• Consistent performance across multiple demographic groups

Validity

• Part A demonstrates moderate sensitivity and excellent specificity for ADHD screening
• Strong convergent validity with clinician-administered ADHD assessments
• Distinguishes well between adults with ADHD and non-ADHD controls
• Factor analyses support its structure across attention and hyperactive-impulsive domains

Kessler et al. (2005) validated the instrument using large-scale population data, contributing to its widespread adoption.

Administration Considerations

• Self-administered in paper or digital formats
• Designed for quick completion with minimal burden
• Works well in primary care, psychiatry, psychology, and workplace evaluations
• Should be administered when the individual is calm and able to reflect on typical functioning
• For individuals with literacy challenges, clinician-supported administration may be appropriate

Limitations

• Screening tool only, not diagnostic
• Self-report bias may influence results
• Does not assess age-of-onset criteria or functional impairment (required for diagnosis)
• Not validated for severe cognitive impairment or unstable psychiatric states
• Cultural and linguistic adaptation may affect validity across populations

ADHD Screening Overview

The ASRS is a two-part screener: Part A (6 items) identifies likely ADHD, while Part B (12 items) provides a more detailed symptom assessment. Across both parts it assesses the three core ADHD symptom domains — inattention, hyperactivity, and impulsivity — across all 18 questions. Part A scoring triggers further evaluation, and the full ASRS supports interpretation of symptom patterns.

Documenting ASRS results in clinical notes: The ASRS Part A score and symptom endorsement count belong in the Objective section of your note. See our SOAP notes guide and intake notes guide for templates and examples.

Frequently Asked Questions

How accurate is the ASRS for diagnosing ADHD?

In the original World Health Organization validation studies (Kessler et al., 2005/2007), the ASRS Part A screener (6 items) demonstrated 68.7% sensitivity and 99.5% specificity in general population and health plan member samples. The very high specificity means a positive screen is highly predictive of ADHD in those settings. However, sensitivity of ~68% means roughly 1 in 3 adults with ADHD may screen negative, a negative result should not rule out ADHD if clinical symptoms are present. A full clinical evaluation is required for diagnosis.

What is ADHD in adults?

Adult ADHD is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity that impairs daily functioning. It affects approximately 4.4% of US adults (Kessler et al., 2006 NCS-R) and is often underdiagnosed, particularly in women.

How is adult ADHD different from childhood ADHD?

In adults, hyperactivity often presents as inner restlessness rather than physical overactivity. Inattention, disorganization, and impulsivity are more prominent symptoms. Adults frequently develop coping strategies that mask symptoms, making screening more important.

What treatments are available for adult ADHD?

Evidence-based treatments for adult ADHD include stimulant medications (methylphenidate, amphetamines), non-stimulant medications (atomoxetine, viloxazine), and Cognitive Behavioural Therapy (CBT). Combined pharmacological and behavioural treatment shows the strongest outcomes.

Can stress or anxiety mimic ADHD on the ASRS?

Yes. Anxiety, depression, sleep disorders, and trauma can produce ADHD-like symptoms. This is why a positive ASRS screen must be followed by clinical evaluation that rules out other conditions, the ASRS is a screener, not a diagnosis.

ASRS vs Other ADHD Screening Tools

Choosing the right ADHD assessment depends on your clinical setting and diagnostic needs. Here's how the ASRS compares to other validated ADHD screening tools.

ASRS vs CAARS: World Health Organization-Validated vs Full Assessment

Clinical Guidance: The ASRS is ideal for high-volume screening in primary care or initial mental health intake. Its Part A (6 questions) provides rapid triage with excellent specificity. Use CAARS when you need detailed symptom profiling across subscales or when conducting detailed diagnostic evaluations. Many clinics use ASRS for screening, then follow positive screens with CAARS for detailed assessment.

When to use ASRS: Fast screening, large patient volumes, primary care settings, free/open-access tool needed, initial intake assessment.

ASRS vs WURS: Current vs Childhood Symptoms

Clinical Guidance: The ASRS screens for current adult ADHD symptoms, while the WURS confirms childhood symptom history, a DSM-5-TR requirement for ADHD diagnosis. In full evaluations, use both: ASRS establishes current impairment, WURS verifies early onset. Note that WURS relies on retrospective recall, which can be unreliable; corroboration from childhood records or family is recommended.

When to use both: A complete ADHD diagnosis requires documenting both current symptoms (ASRS) and childhood onset (WURS or clinical interview). The ASRS alone is sufficient for screening and symptom monitoring.

ASRS-6 (Part A Only) vs Full 18-Item ASRS

Clinical Guidance: Part A alone (ASRS-6) is sufficient for screening in high-volume settings, its 99.5% specificity means very few false positives. Use the full 18-item ASRS when you need a detailed symptom breakdown for treatment planning or when monitoring response to ADHD medication. Part B adds nuance but doesn't significantly improve screening accuracy.

Workflow recommendation: Use ASRS-6 (Part A) for initial screening in primary care. If positive, administer full ASRS + clinical interview for diagnostic confirmation. This two-stage approach balances efficiency with diagnostic accuracy.

Simplify ADHD Screening with HiBoop

Automated ASRS scoring, longitudinal tracking, and integrated treatment monitoring for adult ADHD.